TAQWA_MEDICAL_LTD - Accounts


Company registration number 07562435 (England and Wales)
TAQWA MEDICAL LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023
PAGES FOR FILING WITH REGISTRAR
TAQWA MEDICAL LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 6
TAQWA MEDICAL LTD
BALANCE SHEET
AS AT
31 MARCH 2023
31 March 2023
- 1 -
2023
2022
Notes
£
£
£
£
Fixed assets
Intangible assets
4
1
1
Tangible assets
5
1
1
Investments
6
55,372
29,577
55,374
29,579
Current assets
Debtors
7
159,431
358,081
Cash at bank and in hand
933,826
615,541
1,093,257
973,622
Creditors: amounts falling due within one year
8
(196,866)
(136,461)
Net current assets
896,391
837,161
Net assets
951,765
866,740
Capital and reserves
Called up share capital
300
106
Profit and loss reserves
951,465
866,634
Total equity
951,765
866,740

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 28 March 2024 and are signed on its behalf by:
Dr I S Malik
Director
Company registration number 07562435 (England and Wales)
TAQWA MEDICAL LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023
- 2 -
1
Accounting policies
Company information

Taqwa Medical Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 1st Floor, Gallery Court, 28 Arcadia Avenue, London, N3 2FG.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover represents amounts receivable for services.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
33% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

TAQWA MEDICAL LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
1
Accounting policies
(Continued)
- 3 -
1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

TAQWA MEDICAL LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
1
Accounting policies
(Continued)
- 4 -
1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.11
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Total
5
5
4
Intangible fixed assets
Goodwill
£
Cost
At 1 April 2022 and 31 March 2023
250,000
Amortisation and impairment
At 1 April 2022 and 31 March 2023
249,999
Carrying amount
At 31 March 2023
1
At 31 March 2022
1
TAQWA MEDICAL LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
- 5 -
5
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2022 and 31 March 2023
2,033
Depreciation and impairment
At 1 April 2022 and 31 March 2023
2,032
Carrying amount
At 31 March 2023
1
At 31 March 2022
1
6
Fixed asset investments
2023
2022
£
£
Investments
55,372
29,577
Movements in fixed asset investments
Investments
£
Cost or valuation
At 1 April 2022
29,577
Additions
25,795
At 31 March 2023
55,372
Carrying amount
At 31 March 2023
55,372
At 31 March 2022
29,577
7
Debtors
2023
2022
Amounts falling due within one year:
£
£
Trade debtors
5,980
72,848
Other debtors
153,451
285,233
159,431
358,081
TAQWA MEDICAL LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
- 6 -
8
Creditors: amounts falling due within one year
2023
2022
£
£
Corporation tax
168,360
114,492
Other taxation and social security
4,042
5,227
Other creditors
24,464
16,742
196,866
136,461
2023-03-312022-04-01false28 March 2024CCH SoftwareCCH Accounts Production 2023.300No description of principal activityDr I S MalikDr F Malikfalse075624352022-04-012023-03-31075624352023-03-31075624352022-03-3107562435core:NetGoodwill2023-03-3107562435core:NetGoodwill2022-03-3107562435core:OtherPropertyPlantEquipment2023-03-3107562435core:OtherPropertyPlantEquipment2022-03-3107562435core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-3107562435core:CurrentFinancialInstrumentscore:WithinOneYear2022-03-3107562435core:CurrentFinancialInstruments2023-03-3107562435core:CurrentFinancialInstruments2022-03-3107562435core:ShareCapital2023-03-3107562435core:ShareCapital2022-03-3107562435core:RetainedEarningsAccumulatedLosses2023-03-3107562435core:RetainedEarningsAccumulatedLosses2022-03-3107562435bus:Director12022-04-012023-03-3107562435core:ComputerEquipment2022-04-012023-03-31075624352021-04-012022-03-3107562435core:NetGoodwill2022-03-3107562435core:OtherPropertyPlantEquipment2022-03-3107562435core:WithinOneYear2023-03-3107562435core:WithinOneYear2022-03-3107562435bus:PrivateLimitedCompanyLtd2022-04-012023-03-3107562435bus:SmallCompaniesRegimeForAccounts2022-04-012023-03-3107562435bus:FRS1022022-04-012023-03-3107562435bus:AuditExemptWithAccountantsReport2022-04-012023-03-3107562435bus:Director22022-04-012023-03-3107562435bus:FullAccounts2022-04-012023-03-31xbrli:purexbrli:sharesiso4217:GBP